Indications:
Acute lymphoblastic leukemia
Large B-cell lymphoma<unk><unk>  include:
Cytokine release syndrome
Hypogammaglobulinemia
Pancytopenia
Altered mental status
Acute lymphoblastic leukemia
Large B-cell lymphoma
Cytokine release syndrome
Hypogammaglobulinemia
Pancytopenia
Altered mental status
Indications:
Acute lymphoblastic leukemia
Large B-cell lymphoma<unk><unk>  include:
Cytokine release syndrome
Pancytopenia
Altered mental status
Acute lymphoblastic leukemia
Large B-cell lymphoma
Cytokine release syndrome
Pancytopenia
Altered mental status
Oncologic therapy related adverse events
Decreased cellular immunity which an cause reactivation or new
Paraneoplastic syndromes
Tuberculosis
Post-surgical complications
Sepsis
Intrathecal drug delivery system complications
Fungal infections